Independent Laboratory Testing: How to Verify It's Actually Independent

The Direct Answer

Independent laboratory testing means a Certificate of Analysis was produced by a facility that has no ownership stake, no shared branding or address, no exclusive financial arrangement, and no advance knowledge of which supplier's product it is analysing at the point the test is run. If any one of those conditions fails, the word "independent" on the label is a marketing claim, not a verified fact.

This distinction matters more in the UK research peptide space than almost anywhere else, because there is no statutory pre-market testing regime for unlicensed compounds. Whatever quality assurance exists is the assurance a buyer builds for themselves — and that assurance is only as strong as the independence of the laboratory behind it. The rest of this guide sets out the three tests that separate genuinely independent testing from a certificate that merely uses the word.

Test One — Ownership and Corporate Structure

The first and most basic test is corporate ownership. Does the laboratory share a parent company, director, or majority shareholder with the seller of the product? This information is not always advertised, but in the UK it is frequently a matter of public record. Companies House (gov.uk's company register) lists directors and, in many cases, ultimate beneficial owners for UK-registered companies. If a laboratory and a supplier trace back to the same holding company or the same individual director, the laboratory's test result cannot be treated as an independent check on that supplier's product, regardless of how the certificate is worded.

This is not a hypothetical concern. It is common in loosely regulated markets for a supplier to establish or acquire a testing entity that operates under a different trading name, presenting results as third-party verification when the ownership structure says otherwise.

What to look for

• A laboratory name that is unrelated to the seller's brand — necessary but not sufficient on its own.
• A registered address that differs from the seller's warehouse or office address.
• No shared directors when both entities are searched on the relevant company register.

Test Two — Financial Relationship

The second test goes beyond ownership to the financial arrangement between the laboratory and the party requesting the test. A laboratory can be legally and structurally separate from a supplier and still lack independence in practice, if it depends on that single supplier for the overwhelming majority of its revenue, or if it is paid on a per-favourable-result basis rather than a flat per-test fee.

Reputable independent laboratories are typically paid a standard fee regardless of the outcome, serve a broad client base rather than a single supplier, and apply the same methodology and reporting format to every sample submitted to them, whoever the client is. When a laboratory's entire business model depends on one commercial relationship continuing, its incentive to report an unfavourable result is weakened, even without any explicit wrongdoing on either side.

Test Three — Chain of Custody

The third and most frequently overlooked test is chain of custody: who physically submitted the sample, and did the laboratory know in advance which product it was testing and for whom. Genuine blind or coded sample submission, where a laboratory receives a sample labelled only with a code rather than a brand name, removes any possibility that the result was influenced by knowledge of the client relationship.

Where chain of custody is not blind, at minimum the certificate should record who submitted the sample, the date of submission, and the batch number of the physical product tested — matching the field-by-field detail covered in our guide to reading a UK peptide COA. A certificate with no submission record at all provides no way to confirm the tested sample and the product in front of you are the same thing.

How to Check Accreditation Yourself

Beyond the three independence tests, the laboratory should hold accreditation to ISO/IEC 17025, the international standard for the competence of testing and calibration laboratories. In the UK, the relevant accreditation body is UKAS (the United Kingdom Accreditation Service). Their public register at ukas.com allows you to search a laboratory's exact registered name and confirm which specific test methods, such as HPLC or LC-MS, fall within its accredited scope. Accreditation for one type of test does not automatically extend to another, so checking the scope, not just the existence of accreditation, is essential.

If a laboratory is based outside the UK, look for accreditation from the equivalent national body, or membership of the International Laboratory Accreditation Cooperation (ILAC) mutual recognition arrangement, which allows accreditation bodies in different countries to recognise each other's competence assessments.

Red Flags That the Word "Independent" Is Being Used Loosely

• The COA names a laboratory that does not appear on any national accreditation register.
• The certificate provides no batch number, submission date, or analyst reference alongside the independence claim.
• The laboratory's website or literature is closely branded with, or exclusively promotes, a single product line.
• Requests to confirm the laboratory's registered address or ownership go unanswered.

The MHRA and EMA Context

It is worth restating clearly: independent laboratory testing is a voluntary quality practice, not a legal substitute for regulatory approval. The Medicines and Healthcare products Regulatory Agency (MHRA) is the competent authority for medicines regulation in the United Kingdom under the Human Medicines Regulations 2012, and products supplied for human use without a marketing authorisation from the MHRA fall outside licensed medicine status regardless of any independent test result attached to them. The European Medicines Agency (EMA) sets parallel quality and analytical guidance for medicinal products across the EU, and its published quality guidelines describe the standards that licensed manufacturers are expected to meet — a useful reference point even where a compound itself is unlicensed. Neither agency accredits or endorses individual third-party testing laboratories.

Peer-reviewed literature on peptide analytical methods, indexed through PubMed (the U.S. National Library of Medicine's database), consistently identifies chromatographic methods such as HPLC and LC-MS, performed by a laboratory independent of the manufacturing or supply chain, as the accepted standard for verifying peptide identity and purity in a research context.

Why This Matters More Than the Purity Percentage

A purity figure of 99% means very little if the laboratory reporting it is not independent in ownership, financial relationship, and chain of custody. The number is only as trustworthy as the process that produced it. This is why the three-test framework above should be applied before the purity percentage itself is given any weight — independence is the precondition, not an afterthought, for any COA to be treated as evidence rather than assertion.

Summary

Independent laboratory testing is verifiable, not a matter of trust. Check ownership through the relevant company register, check the financial relationship for signs of single-client dependency, check chain of custody for a documented or blind submission process, and check accreditation scope directly on the UKAS or equivalent national register. A certificate that satisfies all four checks is meaningfully different from one that simply carries the word "independent" on its letterhead. Before acting on any documentation, consult a licensed healthcare professional and review the regulatory status of the specific compound in question.